Pushing science to defeat serious chronic diseases
Novo Nordisk is a leading global healthcare company driven by a simple belief: that health is fundamental to a good life. With more than 100 years of innovation in diabetes care, Novo Nordisk has grown into a global leader in the treatment of obesity, diabetes and other serious chronic diseases, dedicated to defeating them through science, breakthrough treatments and improved access to care.
Obesity
Novo Nordisk develops science-backed treatments for obesity, supporting long-term weight management alongside diet and physical activity for adults living with the disease.
Diabetes
Novo Nordisk develops a comprehensive range of insulins and other therapies for type 1 and type 2 diabetes, supporting better blood sugar management and long-term health outcomes.